Patents by Inventor David John Augustus Eckland

David John Augustus Eckland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
    Publication number: 20190255032
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS)disorders.
    Type: Application
    Filed: December 13, 2018
    Publication date: August 22, 2019
    Applicant: MINORYX THERAPEUTICS S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, David John Augustus ECKLAND, Maria Pilar PIZCUETA LALANZA, Marc MARTINELL PEDEMONTE
  • 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
    Patent number: 10179126
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: January 15, 2019
    Assignee: Minoryx Therapeutics S.L.
    Inventors: Ana Maria García Collazo, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • 2,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System Disorders
    Publication number: 20180133202
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Application
    Filed: October 5, 2017
    Publication date: May 17, 2018
    Applicant: Minoryx Therapeutics S.L.
    Inventors: Ana Maria GARCÍA COLLAZO, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • 2,4-thiazolidinedione derivatives in the treatment of central nervous system disorders
    Patent number: 9782395
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy) benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Grant
    Filed: May 5, 2016
    Date of Patent: October 10, 2017
    Assignee: MINORYX THERAPEUTICS S.L.
    Inventors: Ana María García Collazo, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte
  • 2,4-THIAZOLIDINEDIONE DERIVATIVES IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
    Publication number: 20160235729
    Abstract: The present invention provides 5-(4-(2-(5-(1-hydroxyethyl)pyridine-2-yl)ethoxy) benzyl)thiazolidine-2,4-dione and novel stereoisomers of said compound for use in the treatment of central nervous system (NS) disorders.
    Type: Application
    Filed: May 5, 2016
    Publication date: August 18, 2016
    Applicant: MINORYX THERAPEUTICS S.L.
    Inventors: Ana Maria Garcia Collazo, David John Augustus Eckland, Maria Pilar Pizcueta Lalanza, Marc Martinell Pedemonte